Logo image
Back
Temporal Trends of De Novo Malignancy Development After Heart Transplantation
Journal article   Open access   Peer reviewed

Temporal Trends of De Novo Malignancy Development After Heart Transplantation

Jong-Chan Youn, Josef Stehlik, Amber R. Wilk, Wida Cherikh, In-Cheol Kim, Gyeong-Hun Park, Lars H. Lund, Howard J. Eisen, Do Young Kim, Sun Ki Lee, …
Journal of the American College of Cardiology, v 71(1), pp 40-49
02 Jan 2018
DOI: https://doi.org/10.1016/j.jacc.2017.10.077
PMID: 29301626
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1016/j.jacc.2017.10.077View
Published, Version of Record (VoR) Open

Abstract

heart transplantation immunosuppression malignancy prognosis temporal trends
Malignancy is a concern in cardiac transplant recipients, but the temporal trends of de novo malignancy development are unknown. The goal of this study was to describe the temporal trends of the incidence, types, and predictors of de novo malignancy in cardiac transplant recipients. The authors analyzed the temporal trends of post-transplant incidence, types, and predictors of malignancy using 17,587 primary adult heart-only transplant recipients from the International Society for Heart and Lung Transplantation registry. The main study outcomes included the incidence of, types of, and time to de novo malignancy. The risk of any de novo solid malignancy between years 1 and 5 after transplantation was 10.7%. The cumulative incidence by malignancy type was: skin cancer (7.0%), non-skin solid cancer (4.0%), and lymphoproliferative disorders (0.9%). There was no temporal difference in the time to development according to malignancy type. However, the cumulative incidence of de novo solid malignancy increased from 2000 to 2005 vs. 2006 to 2011 (10.0% vs. 12.4%; p < 0.0001). Survival in patients after de novo malignancy was markedly lower than in patients without malignancy (p < 0.0001). Older recipients and patients who underwent transplantation in the recent era had a higher risk of de novo malignancy. More than 10% of adult heart transplant recipients developed de novo malignancy between years 1 and 5 after transplantation, and this outcome was associated with increased mortality. The incidence of post-transplant de novo solid malignancy increased temporally, with the largest increase in skin cancer. Individualized immunosuppression strategies and enhanced cancer screening should be studied to determine whether they can reduce the adverse outcomes of post-transplantation malignancy. [Display omitted]

Metrics

9 Record Views
76 citations in Web of Science
77 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Cardiac & Cardiovascular Systems
Logo image